ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      18,936.40
      -0.02%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      72.38
      -1.28%
      Bitcoin
      60,791.30
      0.81%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Csl Ltd (QX) (CSLLY) Quote

      Csl Ltd (QX)

      Csl Ltd (QX) (CSLLY)

      USOTC
      100.02
      -0.586
      (-0.58%)
      Closed September 18 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      100.02
      Bid
      99.26
      Ask
      100.17
      Volume
      27,604
      97.72 Day's Range 101.08
      71.51 52 Week Range 109.00
      Market Cap
      96.67B
      Previous Close
      100.606
      Open
      101.08
      Last Trade
      13
      @
      100.02
      Last Trade Time
      Financial Volume
      $ 2,746,721
      VWAP
      99.5044
      Average Volume (3m)
      21,569
      Shares Outstanding
      966,505,458
      Dividend Yield
      -
      PE Ratio
      114.87
      Earnings Per Share (EPS)
      2.73
      Revenue
      14.69B
      Net Profit
      2.64B

      About Csl Ltd (QX)

      CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.csl.com.au
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      1916
      Csl Ltd (QX) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker CSLLY. The last closing price for Csl (QX) was $100.61. Over the last year, Csl (QX) shares have traded in a share price range of $ 71.51 to $ 109.00.

      Csl (QX) currently has 966,505,458 shares outstanding. The market capitalization of Csl (QX) is $97.24 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 114.87.

      Ask ADVFN Intelligence (AI)

      CSLLY Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      9 hours ago

      Form 3 - Initial statement of beneficial ownership of securities

      July 25 2023
      Edgar (US Regulatory)

      CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient

      CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient Awards Program Supports Novel Research of Immunoglobulin Therapy for Neurological Disorders PR Newswire KING OF PRUSSIA, Pa...

      June 29 2015
      PR Newswire (US)

      CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015

      CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015 PR Newswire TORONTO, June 24, 2015 - Data supports prolonged dosing...

      June 24 2015
      PR Newswire (US)

      CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A

      CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A PR Newswire TORONTO, June 24, 2015 Data Presented during Late Breaking Session at...

      June 24 2015
      PR Newswire (US)

      Defining And Differentiating The Value Of Therapies Used To Treat Rare Disease Patients Is A Challenge For Payers

      Defining And Differentiating The Value Of Therapies Used To Treat Rare Disease Patients Is A Challenge For Payers Panel of experts examines how value of biopharmaceutical technologies is assessed...

      June 17 2015
      PR Newswire (US)

      CSL Behring to Present Pivotal Data for rVIII-SingleChain and rIX-FP at 2015 ISTH Congress

      CSL Behring to Present Pivotal Data for rVIII-SingleChain and rIX-FP at 2015 ISTH Congress PR Newswire KING OF PRUSSIA, Pa., June 16, 2015 More than 20 abstracts focusing on investigational and...

      June 16 2015
      PR Newswire (US)

      Important New Findings Published in The Lancet Support the Use of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients...

      Important New Findings Published in The Lancet Support the Use of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients with Alpha-1 Antitrypsin Deficiency (AATD) PR Newswire KING OF...

      June 01 2015
      PR Newswire (US)

      National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award

      National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award CSL Behring Recognized for its Longstanding Commitment to Delivering Innovative Products and Programs that...

      May 22 2015
      PR Newswire (US)

      Science, Information, And Technology Driving Evolution Of Global Healthcare

      Science, Information, And Technology Driving Evolution Of Global Healthcare Industry serves critical role in advancing healthcare and improving the well-being of patients, says CSL CEO Paul...

      May 14 2015
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.505-0.502362596369100.525105.6697.7220689101.17471525DR
      4-5.305-5.03679088535105.32510995.0521227102.86766378DR
      121.941.977977161598.0810995.0521569101.34837941DR
      268.379.132569558191.6510985.962879095.32155483DR
      5214.0216.30232558148610971.514804087.97511129DR
      156-10.86-9.79437229437110.88117.2471.516401692.85834302DR
      26019.2923.894463024980.73117.9871.515680695.86719208DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GIPLGlobal Innovative Platforms Inc (CE)
      $ 0.10
      (9,999,900.00%)
      		605
      ZHCLFZenith Capital Corporation (CE)
      $ 0.07
      (6,999,900.00%)
      		5.54k
      AUSAFAustralis Capital Inc (CE)
      $ 0.0101
      (1,009,900.00%)
      		9.26k
      ZAAGZA Group Inc (PK)
      $ 0.0001
      (9,900.00%)
      		512.76k
      NWPNNow Corp (PK)
      $ 0.0001
      (9,900.00%)
      		5.76M
      PFTIPuradyn Filter Technologies Inc (CE)
      $ 0.000001
      (-99.96%)
      		200k
      GENNGenesis Healthcare Inc (CE)
      $ 0.000001
      (-99.91%)
      		2k
      ATHXQAthersys Inc New (CE)
      $ 0.000001
      (-99.90%)
      		968
      STIXFSemantix Inc (CE)
      $ 0.0002
      (-99.88%)
      		1.76k
      GOSYGeckosystems International Corp (CE)
      $ 0.000001
      (-99.33%)
      		1M
      AAPJAAP Inc (PK)
      $ 0.0003
      (-40.00%)
      		559.12M
      AMLHAmerican Leisure Holdings Inc (PK)
      $ 0.0003
      (0.00%)
      		142.01M
      ASIIAccredited Solutions Inc (PK)
      $ 0.0006
      (0.00%)
      		108.17M
      HMBLHUMBL Inc (PK)
      $ 0.00015
      (50.00%)
      		100.64M
      HCMCHealthier Choices Management Corporation (PK)
      $ 0.000001
      (-98.00%)
      		95.68M

      Discussion

      View Full Feed
      zakattack zakattack 2 minutes ago
      If there was gold he would pr now when gold is at all time high that's how I know he doesn't have anything
      GNCP
      sab63090 sab63090 2 minutes ago
      Ken:
      We recently learned that my wife who never has had ANY medical problems has just been prescribed some drops which I have to put in every day for her since they see glaucoma developing and is scheduled to see our ophthalmologist on 9/24...she was referred to someone who handles both glauc
      AVXL
      Charlie3274 Charlie3274 2 minutes ago
      As much as 560 million is a lot of volume it really was only $260,000 in contrast $580 million was traded today on AT&T lol and that’s like daily
      AAPJ
      blackhawks blackhawks 3 minutes ago
      No, enlighten us.
      Scarface Scarface 3 minutes ago
      I was reading some of my Dad’s old posts. Alonzo sure is some character. All the hate that came his way attempting to expose Alonzo. My dad is dead and Alonzo keeps on going. Who says crime doesn’t pay
      BLQC
      SkyLimit2022 SkyLimit2022 3 minutes ago
      Investor082,

      I like your question! it’s actually thought-provoking instead of just provoking as your comments usually are. Do all the PD-1 drug companies count as BP?

      UCLA and Roswell are both investigating PD-1 in combo with dendritic cell vaccination. I think that
      NWBO
      jay_tee jay_tee 3 minutes ago
      Let’s wait to acknowledge that once the CEO of FOXO actually confirms that. He’s the one releasing press releases and signing documents for FOXO not Seamus Lagan. Or do you mean RNVA is actually running the show underneath the table? If so, we are screwed! Lol
      FOXO RNVA
      oystersnbeer oystersnbeer 3 minutes ago
      Trump second assassination attempt two months after the first.

      What took so long?
      TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 4 minutes ago
      Yea! Like me! You know? One thing I learned long ago is that I should model those who are successful and I see CJ as someone who is a successful trader so I follow CJ. Perhaps you should too.
      Just sayin.
      AAPJ
      blackhawks blackhawks 4 minutes ago
      They were listening to the Trumpanzees who apparently weren't aware how far inflation had dropped....from 9% to 2.5%....because it was so much fun to claim we were better off under Trump.
      PioneerPhoenix73 PioneerPhoenix73 4 minutes ago
      So, let's break down this wild theory about a "specialized disinformation agent" whose sole purpose is to... well, be absurd. It's like a real-life plot twist from a late-night comedy sketch.

      Point 1: The "Unrelenting Shadow of Doubt"

      The idea that this "absurdist" can
      SINT
      bigtalan bigtalan 5 minutes ago
      Thanks for update , nice 15k gain today GLTA
      RSPI
      nagoya1 nagoya1 5 minutes ago
      The wsj article from 2008 continues to be as useless as all the other gse skateboarding guru like evaluations.

      I wouldn’t clean my dog’s butt with their lack of in depth gse journalism.
      Bla bla china has nothing to do with today’s gse reality.

      When has the wsj
      FNMA
      rs99 rs99 5 minutes ago
      Two things for sure. Doesn’t appear to be diluted and the pps is very slowly inching down over time. How long ago was the pps at .012? Been a while. My only alerts are it is slow walking down. Mister magic man keeps pumping this to no avail. But it isn’t crashing. Kind of makes you wonder who he mig
      FRZT
      ap17 ap17 5 minutes ago
      Correct, and they know they will lose.

      Democrats are pushing violence against him at every chance they get, they know very well there are a lot of whackos out there, and so do it.
      XRPUSD
      misterfishman misterfishman 5 minutes ago
      Name change happen and this is a game changer cause then they will begin to dump the rest of their business into the new ticker and dollar bound we go but the time line?Who knows that's why I am very long here.
      IGPK
      HokieHead HokieHead 7 minutes ago
      She shouldn’t be mad if she’s here for the merger, management change, name/ticker change and even maybe dividends to name a few.

      Watch when all the “I sold but buying millions back” and chart was too hot etc all try and get back in, 8s won’t be had 😉..
      BNCM
      arizona1 arizona1 7 minutes ago
      If those are his....then the parents will be in trouble depending on the jurisdiction.

      What do you think the punishment should be for the parent who is grooming their kid to become a mass shooter by gifting their 11 year old child all these weapons?
      Konaploinks Konaploinks 8 minutes ago
      40 months doc. Nothing has happened. U willing to wait another 40 months? AI will eat your lunch soon. Ken needs to chit or get off the pot. Enough of the slow walk Have we been set up? Looks like it to me. No communication. Mushroom treatment after he promised us he would be different from Wade.
      dstock07734 dstock07734 8 minutes ago
      We should include the trials on Opdivo too.
      NWBO
      blackhawks blackhawks 8 minutes ago
      West Coast Teamsters break with national chapter in endorsing Harris

      https://www.politico.com/news/2024/09/18/west-coast-teamsters-endorse-harris-00179923

      West Coast Teamsters announced their endorsement of Vice President Kamala Harris on Wednesday, just minutes after n
      Huggy Bear Huggy Bear 9 minutes ago
      Not many interested in this .0001 scam, Dragon
      KEGS
      stealofadeal stealofadeal 9 minutes ago
      $RDAR Are you kidding me? On the ask the .0003 kept loading up as it thinned out. I know this CEO and even spoke to him a few times. He encouraged me to send him money for shares. Stating you can’t help the company buying on the open market. What really means is you can’t help him. He’s a scammer.
      RDAR
      delerious1 delerious1 9 minutes ago
      CHARBONE Hydrogen Initiates Discussion with Natural Hydrogen Exploration Companies, is Reviewing and Exploring the Potential to Create an Added-Value
      V.CH | 11 hours ago
      (TheNewswire)

      Charbone Hydrogen Corporation

      Brossard, Quebec – TheNewswire - Septem
      CHHYF

      Your Recent History

      USOTC
      CSLLY
      Csl (QX)
      Delayed Upgrade Clock